ReviewTherapeutic advances in endocrinology and metabolism2023

Tolvaptan for the treatment of the syndrome of inappropriate antidiuresis (SIAD).

Ploutarchos Tzoulis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.